BrainsWay’s treatment platform is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas.
The treatment features unique, patented coils that are fitted into a helmet, which is secured snugly to the patient’s head during the treatment. BrainsWay’s therapy has been utilized in over 60 clinical trials worldwide. In the U.S., the company’s device has been FDA cleared for the treatment of Major Depressive Disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD).
Learn more about how BrainsWay’s innovative technology can be effective in treating psychiatric disorders.
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
Bipolar disorder, also known as manic-depressive illness
Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia
Tobacco smoking is the leading cause of preventable death in developed countries.
Learn more about how BrainsWay’s innovative technology can be effective in treating neurological disorders.
Alzheimer's disease is a major cause of severe cognitive decline in the aged.
Autism is a complex developmental disability that typically appears during the first three years of life
Neuropathy is common in the diabetic population, affecting approximately 50% of patients with long-lasting diseases.
Multiple Sclerosis (MSc) is an inflammatory demyelinating condition of the central nervous system
Parkinson's disease is a degenerative disorder of the central nervous system
A brain stroke is the loss of brain function due to a disturbance in the blood supply to the brain.